Sommario
La disforia di genere (DG) in età evolutiva è un fenomeno multifattoriale caratterizzato da disagio clinicamente significativo per l’incongruenza tra identità di genere e sesso biologico. La DG in adolescenza è associata a depressione, ansia, ritiro sociale e rischio suicidario. Tutte le linee guida e raccomandazioni nazionali e internazionali supportano l’uso dei GnRH analoghi in casi selezionati di adolescenti con DG per alleviare il disagio e per ampliare la finestra diagnostica.
Bibliografia
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5 edn. DSM-5, Washington, DC
WHO (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva
Steensma TD, Kreukels BP, de Vries AL et al. (2013) Gender identity development in adolescence. Horm Behav 64:288–297
de Vries AL, Cohen-Kettenis PT (2012) Clinical management of gender dysphoria in children and adolescents: the Dutch approach. J Homosex 59:301–320
Coleman E, Bockting W, Botzer M et al. (2011) Standards of care for the health of transsexual. transgender, and gender-nonconforming people, version 7. Int J Transgend 13:165–232
Drescher J (2014) Controversies in gender diagnoses. LGBT Health 1:10–14
Shumer DE, Spack NP (2013) Current management of gender identity disorder in childhood and adolescence: guidelines, barriers and areas of controversy. Curr Opin Endocrinol Diabetes Obes 20:69–73
de Vries AL, Steensma TD, Cohen-Kettenis PT et al. (2016) Poor peer relations predict parent- and self-reported behavioral and emotional problems of adolescents with gender dysphoria: a cross-national, cross-clinic comparative analysis. Eur Child Adolesc Psychiatry 6:579–588
Fisher AD, Ristori J, Bandini E et al. (2014) Medical treatment in gender dysphoric adolescents endorsed by SIAMS-SIE-SIEDP-ONIG. J Endocrinol Invest 37:675–687
Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA et al. (2009) Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:3132–3154
Vlot MC, Klink DT, den Heijer M et al. (2017) Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents. Bone 95:11–19
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflitto di interesse
Gli autori Jiska Ristori, Alessandra Daphne Fisher, Elisa Maseroli, Giovanni Castellini, Valdo Ricca e Mario Maggi dichiarano di non avere conflitti di interesse.
Consenso informato
Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.
Studi sugli animali
Gli autori di questo articolo non hanno eseguito studi sugli animali.
Additional information
Proposto da Francesco Trimarchi.
Materiale elettronico supplementare
Rights and permissions
About this article
Cite this article
Ristori, J., Fisher, A.D., Maseroli, E. et al. La disforia di genere in età evolutiva. L'Endocrinologo 19, 79–84 (2018). https://doi.org/10.1007/s40619-018-0440-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-018-0440-5